Next Article in Journal
Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma
Previous Article in Journal
Slow Sulfide Donor GYY4137 Increased the Sensitivity of Two Breast Cancer Cell Lines to Paclitaxel by Different Mechanisms
Previous Article in Special Issue
The Role of Trace Elements and Minerals in Osteoporosis: A Review of Epidemiological and Laboratory Findings
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Hereditary Transthyretin Amyloidosis (hATTR) with Polyneuropathy Clusters Are Located in Ancient Mining Districts: A Possible Geochemical Origin of the Disease

by
Per M. Roos
1,2,* and
Sebastian K. T. S. Wärmländer
3,4,*
1
Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden
2
Department of Physiology, St. Göran Hospital University Unit, 11281 Stockholm, Sweden
3
Chemistry Section, Stockholm University, 10691 Stockholm, Sweden
4
CellPept Sweden AB, Kvarngatan 10B, 11847 Stockholm, Sweden
*
Authors to whom correspondence should be addressed.
Biomolecules 2024, 14(6), 652; https://doi.org/10.3390/biom14060652
Submission received: 29 March 2024 / Revised: 12 May 2024 / Accepted: 27 May 2024 / Published: 3 June 2024

Abstract

:
Hereditary transthyretin amyloidosis (hATTR) with polyneuropathy (formerly known as Familial Amyloid Polyneuropathy (FAP)) is an endemic amyloidosis involving the harmful aggregation of proteins, most commonly transthyretin (TTR) but sometimes also apolipoprotein A-1 or gelsolin. hATTR appears to be transmitted as an autosomal dominant trait. Over 100 point mutations have been identified, with the Val30Met substitution being the most common. Yet, the mechanism of pathogenesis and the overall origin of hATTR remain unclear. Here, we argue that hATTR could be related to harmful metal exposure. hATTR incidence is unevenly distributed globally, and the three largest defined clusters exist in Japan, Portugal, and Sweden. All three disease regions are also ancient mining districts with associated metal contamination of the local environment. There are two main mechanisms for how harmful metals, after uptake into tissues and body fluids, could induce hATTR. First, the metals could directly influence the expression, function, and/or aggregation of the proteins involved in hATTR pathology. Such metal–protein interactions might constitute molecular targets for anti-hATTR drug design. Second, metal exposure could induce hATTR -associated genetic mutations, which may have happened several generations ago. These two mechanisms can occur in parallel. In conclusion, the possibility that hATTR could be related to metal exposure in geochemically defined regions deserves further attention.

1. Introduction

Hereditary transthyretin amyloidosis (hATTR) with polyneuropathy (formerly known as Familial Amyloid Polyneuropathy (FAP)) is an endemic amyloidosis with variable clinical presentations characterised by the aggregation of proteins into harmful amyloid material. The most common aggregating protein is transthyretin (TTR), but aggregates of apolipoprotein A-1 and gelsolin are also observed [1]. For hATTR, the initial symptoms are loss of pain and temperature sensation in the feet caused by a length-dependent neuropathy, evolving into muscle weakness and paresis of feet and legs, autonomic failure with gastrointestinal symptoms, cardiomyopathy [1], sexual dysfunction and finally anal sphincter weakness [2]. The first symptoms appear at about 30 years of age, and the survival time is highly variable but may be, on average, ten years from diagnosis [1]. As TTR is mainly produced in the liver, orthotopic liver transplantations have been performed in an attempt to eliminate the source of TTR, with variable success [3]. The US Food and Drug Administration has approved several drugs against hATTR [4] such as the following: tafamidis, which blocks the rate-limiting step of TTR aggregation by inhibiting TTR tetramer dissociation [5]; patisiran, which inhibits the expression of both the variant and wt-TTR [6]; and inotersen, antisense oligonucleotides which cause degradation of the mutant and wt-TTR mRNA [7].
Hereditary transthyretin amyloidosis with polyneuropathy appears to be transmitted as an autosomal dominant trait. The most common mutation is the Val30Met substitution, although more than 100 other amyloidogenic point mutations [8] have been described at various geographic locations across the world (Figure 1). Yet some individuals with the TTR mutation never develop the clinical characteristics associated with hATTR [9], and a few patients with hATTR do not show any family history of the disease [9]. To what extent an environmental component contributes to hATTR seems unresolved [10]. One study has reported that genetic variants located in the non-coding regions of the TTR gene affect the clinical outcome of the disease [11]. Even though significant progress has been made in understanding—and treating—hATTR at the molecular level, the mechanism of pathogenesis and the overall origin of the disease remain unclear [12,13].
It has previously been argued that some neurodegenerative diseases could be related to metal exposure [14,15,16,17], possibly of geochemical origin [18,19]. Here, we investigate and discuss if such metal exposure could be a potential contributing factor for hATTR onset.

2. Materials and Methods

In this study, we investigate the hypothesis that hATTR incidence could be related to geochemical properties of different geographic locations. The approach is straight-forward. First, we review previous studies to identify the largest geographical clusters of hATTR incidence, which are unevenly distributed over the planet. Then, we review earlier studies to characterise the geochemical properties at these locations. Finally, we compare the geochemistry at the different hATTR clusters and attempt to find common features that could be related to hATTR pathogenesis.

3. Results

The incidence of hATTR is known to be unevenly distributed over various geographic regions (Figure 1). There is a general agreement in the published literature that the three largest defined hATTR clusters are located in Japan, Northern Portugal, and Northern Sweden [1,8,20,21]. Interestingly, all these three regions are ancient mining districts. In our opinion, this is probably not a coincidence. Below, we present details of these hATTR clusters and the geochemistry at their locations.

3.1. Japan

In Japan, three distinctive endemic hATTR foci have been described as follows: Arao city in the Kumamoto prefecture, Ogawa village in the Nagano prefecture, and Noto peninsula in the Ishikawa prefecture [8]. Japan is perforated with coal mines and mines for metals such as As, Au, Cd, Cr, Cu, Fe, Hg, Mn, Ni, Pb, Sn, U, and W. Specifically, Arao has been a mining town since the 18th century with seven mines within the city itself, and Arao also has the largest coal mine harbour in Japan, i.e., the Port of Miike. The small mountain village of Ogawa is located at the confluence of several water streams draining the surrounding volcanic slopes. The Noto peninsula hosts the historical Togi metal mining fields [22] together with the Searashi Mn mine in the volcanic regions of the Noto peninsula, Ishikawa prefecture. The geological rationale for all these mines is that Japan is located where the Eurasian tectonic plate met the Izanagi plate some 70 million years ago. It should be noted that coal mining is associated with the release of metals with genotoxic properties [23], often found in elevated concentrations in coal mine tailings and waste, and leaching into agricultural soils typically in a concentration sequence of As > Zn > Ni > Cd > Cr > Cu > Pb [24]. Coal often also contains U [25] with known neurotoxic and genotoxic properties [26].

3.2. Portugal

In Portugal, hATTR is known as Mal dos pèsinhos or Foot-disease, which originally was described among fishermen from Póvoa de Varzim, north of Porto [21]. However, the entire northern coast of Portugal has presented cases, and this is the location of the largest hATTR cluster in the world [1]. Portugal is located in a geological zone with diverse mineral deposits and possible tectonic activity [27], where deposits of Sn, U, and W—tungsten (W) often follows tin ores—are present in the northern regions. Mining activities in Northern Portugal have been documented since prehistoric time [28,29,30]. The extensive Iberian tin belt concentrates in Northwestern Portugal, where the rivers flowing through the Iberian tin-rich areas follow a path westward with their lower course in Portuguese territory, eventually reaching the Atlantic coast [28,29]. Abandoned U mines are located east of Póvoa de Varzim, where runoffs may contaminate the groundwater and drain into the ocean. The environmental exposure is likely increased by the use of agricultural fertilisers, which are known to increase the solubility of U and its leach into the environment [31]. Thus, elevated concentrations of radionuclides in fish muscle have been detected, relating to past U mining in the rivers of Portugal [32].
The Atlantic Ocean west of Portugal is a seismically active zone where the Azores-Gibraltar Transform Fault Zone (AGFZ) has produced several large-magnitude earthquakes and volcanoes. In the original description of hATTR from Portugal [21], the index case fisherman describes the ingestion of large quantities of sea water in a drowning accident before deterioration in hATTR. No data on metal concentrations in the ocean above the AGFZ exist, but measurements in the Ave river flowing through Povoa de Varzim into the ocean have shown significantly elevated concentrations of neurotoxic metals [33]. To what extent these high metal concentrations emanate from volcanic rock along the AGFZ, from mining activities in Northern Portugal, or from metal exposure from textile, tanning, plastic, metal plating and rubber industries in the region remains to be elucidated. Either way, the possibility that Portuguese hATTR fishermen families have been subject to metal exposure from the waters west of Povoa de Varzim should be further explored.
The hATTR foci in Brazil and Mallorca—4th and 5th largest in the world—might be related to the large hATTR cluster in Portugal. Indeed, Portuguese ancestry has been found in almost all the Brazilian cases, which display overall the same disease characteristics as the most common Portuguese FAP type I patients, including the Val30Met mutation [34,35]. This mutation also dominates in the patients from Mallorca, which could have Portuguese origins [36,37]. However, Mallorca and Menorca were once mining islands [38,39,40]. Thus, independent origins of the Val to Met mutation, possibly induced by metal exposure, should not be excluded [41].

3.3. Sweden

In Sweden, a distinctive hATTR cluster exists in the northern municipality of Skellefteå [1,20,42], where mining activities for Ag, As, Au, Cu, Pb, and Zn have been ongoing for several centuries. Twenty-eight different metal mines have been opened in the Skellefteå mining district, which hold massive sulphide deposits hosted in metavolcanic rocks. Uranium minerals are also present [43]. Sweden is located in the region of Baltic bedrock and is therefore geologically stable. But in a palaeotectonic context, the Skellefteå district has been a collision site for tectonic plates [43], akin to the situation in Japan, which explains the large amounts of minerals present. In addition, local clustering of hATTR families has been described in the municipalities of Piteå and Lycksele, close to Skellefteå [20,44,45]. These cases might relate to common ancestors in Skellefteå but could also be connected to historic mining activities in the Piteå (Fe, Ag) and Lycksele (Zn, Cu, Ag, Au) regions.

4. Discussion and Conclusions

The fact that the three largest hATTR clusters are located in ancient mining districts suggest that hATTR could be related to harmful metal exposure. Specifically, the described clusters are located in seaside mining districts, where major metal exposure routes are enteric exposure by ingestion of fish and by drinking of well water [46]. There are two main mechanisms for the possible biological effects of metal exposure in hATTR, after its uptake into tissues and body fluids. In the first scenario, the metals directly affect the expression, function, and/or aggregation of the proteins involved in hATTR pathology, i.e., TTR, apolipoprotein A-1, and gelsolin. In the second scenario, metal exposure induces the mutations associated with hATTR, such as the TTR Val30Met mutation. A combination of these two mechanisms is possible. Both mechanisms could be tested at the molecular level with future biochemical experiments. In the second scenario, the disease-related mutations may have occurred several generations ago. The general conclusion would then be that exposure to neurotoxic and genotoxic metals from mining activities can induce adverse health effects. This would not be a novel observation. In the first scenario, the damaging metal–protein interactions are continually ongoing in hATTR patients. The primary line of defence against such possibly damaging interactions is the prevention of metal exposure. However, in already exposed individuals, these metal–protein interactions may constitute molecular targets for anti-hATTR drug design. It should be noted that this suggested explanatory model, which involves exposure to metals with neurotoxic and genotoxic properties, also takes into account the previously observed and yet unexplained huge variation in penetrance between foci [44,45], as well as the wide variation in age of onset for identical twins [42,47] and neighbouring foci [20]. In conclusion, the possibility that hATTR might be related to metal exposure in geochemically defined regions deserves further attention.

Author Contributions

Conceptualization, P.M.R. and S.K.T.S.W.; methodology, P.M.R. and S.K.T.S.W.; validation, P.M.R. and S.K.T.S.W.; formal analysis, P.M.R. and S.K.T.S.W.; investigation, P.M.R. and S.K.T.S.W.; resources, P.M.R.; data curation, S.K.T.S.W.; writing-original draft preparation, P.M.R. and S.K.T.S.W.; writing-review and editing, P.M.R. and S.K.T.S.W.; visualization, P.M.R.; funding acquisition, P.M.R. and S.K.T.S.W. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by grants from the Kamprad Research Foundation, grant #20200063, the Ulla-Carin Lindquist Foundation for ALS Research, grant #8024247192, and the Magnus Bergvall foundation, grant #202104517, to P.M.R., and from the Magnus Bergvall foundation, grant #2023-907, to S.K.T.S.W.

Data Availability Statement

All datasets generated and/or analysed during the current study are included in the manuscript.

Conflicts of Interest

The authors declare no conflicts of interest. S.K.T.S.W. is a shareholder in Cell–Pept Sweden AB. Neither this company nor the funding organisations had any role in the design of the study; in the collection, analyses, or interpretation of the data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Plante-Bordeneuve, V.; Said, G. Familial amyloid polyneuropathy. Lancet Neurol. 2011, 10, 1086–1097. [Google Scholar] [CrossRef] [PubMed]
  2. Lopes, R.A.; Coelho, T.; Barros, A.; Sousa, M. Corino de Andrade disease: Mechanisms and impact on reproduction. JBRA Assist. Reprod. 2017, 21, 105–114. [Google Scholar] [CrossRef]
  3. Benson, M.D. Liver transplantation and transthyretin amyloidosis. Muscle Nerve 2013, 47, 157–162. [Google Scholar] [CrossRef]
  4. Yokoyama, T.; Mizuguchi, M. Transthyretin Amyloidogenesis Inhibitors: From Discovery to Current Developments. J. Med. Chem. 2020, 63, 14228–14242. [Google Scholar] [CrossRef]
  5. Bulawa, C.E.; Connelly, S.; DeVit, M.; Wang, L.; Weigel, C.; Fleming, J.A.; Packman, J.; Powers, E.T.; Wiseman, R.L.; Foss, T.R.; et al. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc. Natl. Acad. Sci. USA 2012, 109, 9629–9634. [Google Scholar] [CrossRef]
  6. Adams, D.; Polydefkis, M.; González-Duarte, A.; Wixner, J.; Kristen, A.V.; Schmidt, H.H.; Berk, J.L.; López, I.A.L.; Dispenzieri, A.; Quan, D.; et al. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Lancet Neurol. 2021, 20, 49–59. [Google Scholar] [CrossRef]
  7. Brannagan, T.H.; Coelho, T.; Wang, A.K.; Polydefkis, M.J.; Dyck, P.J.; Berk, J.L.; Drachman, B.; Gorevic, P.; Whelan, C.; Conceição, I.; et al. Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update. J. Neurol. 2022, 269, 6416–6427. [Google Scholar] [CrossRef] [PubMed]
  8. Araki, S.; Ando, Y. Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967–2010). Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2010, 86, 694–706. [Google Scholar] [CrossRef] [PubMed]
  9. Sekijima, Y. Hereditary Transthyretin Amyloidosis, in GeneReviews® [Internet]; Adam, M.E.A., Ed.; University of Washington: Seattle, WA, USA, 2001. [Google Scholar]
  10. González-Duarte, A.; Soto, K.C.; Martínez-Baños, D.; Arteaga-Vazquez, J.; Barrera, F.; Berenguer-Sanchez, M.; Cantu-Brito, C.; García-Ramos, G.; Vidal, B.E. Familial amyloidosis with polyneuropathy associated with TTR Ser50Arg mutation. Amyloid 2012, 19, 171–176. [Google Scholar] [CrossRef]
  11. Iorio, A.; De Lillo, A.; De Angelis, F.; Di Girolamo, M.; Luigetti, M.; Sabatelli, M.; Pradotto, L.; Mauro, A.; Mazzeo, A.; Stancanelli, C.; et al. Non-coding variants contribute to the clinical heterogeneity of TTR amyloidosis. European journal of human genetics. Eur. J. Hum. Genet. 2017, 25, 1055–1060. [Google Scholar] [CrossRef]
  12. Benson, M.D.; Kincaid, J.C. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007, 36, 411–423. [Google Scholar] [CrossRef] [PubMed]
  13. Tseng, W.; Huang, H.; Li, C.; Chang, C.; Chan, W.P.; Lin, K.; Wu, C. Natural history and survival rate of familial amyloidosis with polyneuropathy: A nationwide databank. Ann. Clin. Transl. Neurol. 2023, 10, 779–786. [Google Scholar] [CrossRef] [PubMed]
  14. Koski, L.; Ronnevi, C.; Berntsson, E.; Wärmländer, S.K.T.S.; Roos, P.M. Metals in ALS TDP-43 Pathology. Int. J. Mol. Sci. 2021, 22, 12193. [Google Scholar] [CrossRef] [PubMed]
  15. Li, K.; Li, A.; Mei, Y.; Zhao, J.; Zhou, Q.; Li, Y.; Yang, M.; Xu, Q. Trace elements and Alzheimer dementia in population-based studies: A bibliometric and meta-analysis. Environ. Pollut. 2023, 318, 120782. [Google Scholar] [CrossRef] [PubMed]
  16. Koski, L.; Tshoni, U.A.; Olowoyo, J.O.; Kobyana, A.S.; Lion, N.G.; Mugivhisa, L.L.; Warmlander, S.K.; Roos, P.M. Occupational lead exposure in gasoline station forecourt attendants and other occupations in relation to ALS (amyotrophic lateral sclerosis) risk. medRxiv 2023. [Google Scholar] [CrossRef]
  17. Warmlander, S.K.T.S.; Osterlund, N.; Wallin, C.; Wu, J.; Luo, J.; Tiiman, A.; Jarvet, J.; Graslund, A. Metal binding to the amyloid-beta peptides in the presence of biomembranes: Potential mechanisms of cell toxicity. J. Biol. Inorg. Chem. 2019, 24, 1189–1196. [Google Scholar] [CrossRef]
  18. Vasta, R.; Callegaro, S.; Sgambetterra, S.; Cabras, S.; Di Pede, F.; De Mattei, F.; Matteoni, E.; Grassano, M.; Bombaci, A.; De Marco, G.; et al. Presymptomatic geographical distribution of ALS patients suggests the involvement of environmental factors in the disease pathogenesis. J. Neurol. 2023, 270, 5475–5482. [Google Scholar] [CrossRef]
  19. Åström, M.E.; Roos, P.M. Geochemistry of multiple sclerosis in Finland. Sci. Total Environ. 2022, 841, 156672. [Google Scholar] [CrossRef]
  20. Hellman, U.; Suhr, O. Regional differences and similarities of FAP in Sweden. Amyloid 2012, 19, 53–54. [Google Scholar] [CrossRef]
  21. Andrade, C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952, 75, 408–427. [Google Scholar] [CrossRef]
  22. Hamada, M.; Kobayashi, W.; Hiramatsu, Y.; Hasebe, N. Mineralogy, chronology and formation process of the epithermal gold–silver vein deposits in the historical Togi mine, Noto Peninsula, Japan. Resour. Geol. 2022, 72, e12294. [Google Scholar] [CrossRef]
  23. Kopp, B.; Zalko, D.; Audebert, M. Genotoxicity of 11 heavy metals detected as food contaminants in two human cell lines. Environ. Mol. Mutagen. 2018, 59, 202–210. [Google Scholar] [CrossRef]
  24. Li, H.; Xu, W.; Dai, M.; Wang, Z.; Dong, X.; Fang, T. Assessing heavy metal pollution in paddy soil from coal mining area, Anhui, China. Environ. Monit. Assess. 2019, 191, 518. [Google Scholar] [CrossRef] [PubMed]
  25. Lauer, N.; Vengosh, A.; Dai, S. Naturally Occurring Radioactive Materials in Uranium-Rich Coals and Associated Coal Combustion Residues from China. Environ. Sci. Technol. 2017, 51, 13487–13493. [Google Scholar] [CrossRef] [PubMed]
  26. Berntsson, E.; Vosough, F.; Noormagi, A.; Padari, K.; Asplund, F.; Gielnik, M.; Paul, S.; Jarvet, J.; Tõugu, V.; Roos, P.M.; et al. Characterization of uranyl (UO22+) ion binding to amyloid beta (Aβ) peptides: Effects on Aβ structure and aggregation. ACS Chem. Neurosci. 2023, 14, 2618–2633. [Google Scholar] [PubMed]
  27. Duarte, J.C.; Rosas, F.M.; Terrinha, P.; Schellart, W.P.; Boutelier, D.; Gutscher, M.A.; Ribeiro, A. Are subduction zones invading the Atlantic? Evidence from the southwest Iberia margin. Geology 2013, 41, 839–842. [Google Scholar] [CrossRef]
  28. Meunier, E.; Dias, F.; Fonte, J.; Lima, A.; Rodrigues, A.; Bottaini, C.; Silva, R.J.C.; Veiga, J.P.; Pereira, M.F.C.; Figueiredo, E. Later prehistoric tin mining in the Ervedosa mine (Vinhais, Portugal): Evidence and context. Archaeol. Anthropol. Sci. 2023, 15, 43. [Google Scholar] [CrossRef]
  29. Comendador Rey, B.; Meunier, E.; Figueiredo, E.; Lackinger, A.; Fonte, J.; Fernández, C.F.; Lima, A.; Mirão, J.; Silva, R.J. Northwestern Iberian Tin Mining from Bronze Age to Modern Times: An overview. In The Tinworking Landscape of Dartmoor in a European Context; Newman, P., Ed.; Dartmoor Tinworking Research Group: Exeton, UK, 2017; pp. 133–153. [Google Scholar]
  30. Emslie, S.D.; Silva, A.M.; Valera, A.; Vila, E.V.; Melo, L.; Curate, F.; Fidalgo, D.; Inácio, N.; Moreno, M.M.; Cambra-Moo, O.; et al. The use and abuse of cinnabar in Late Neolithic and Copper Age Iberia. Int. J. Osteoarchaeol. 2022, 32, 202–214. [Google Scholar]
  31. Nolan, J.; Weber, K.A. Natural uranium contamination in major US aquifers linked to nitrate. Environ. Sci. Technol. Lett. 2015, 2, 215–220. [Google Scholar] [CrossRef]
  32. Carvalho, F.P.; Oliveira, J.M.; Lopes, I.; Batista, A. Radionuclides from past uranium mining in rivers of Portugal. J. Environ. Radioact. 2007, 98, 298–314. [Google Scholar] [CrossRef]
  33. Soares, H.; Boaventura, R.; Machado, A.; da Silva, J.E. Sediments as monitors of heavy metal contamination in the Ave river basin (Portugal): Multivariate analysis of data. Environ. Pollut. 1999, 105, 311–323. [Google Scholar] [CrossRef] [PubMed]
  34. Cruz, M.W. Regional differences and similarities of familial amyloidotic polyneuropathy (FAP) presentation in Brazil. Amyloid 2012, 19 (Suppl. S1), 65–67. [Google Scholar] [CrossRef] [PubMed]
  35. Bittencourt, P.L.; Couto, C.A.; Clemente, C.; Farias, A.Q.; Palacios, S.A.; Mies, S.; Goldberg, A.C. Phenotypic expression of familial amyloid polyneuropathy in Brazil. Eur. J. Neurol. 2005, 12, 289–293. [Google Scholar] [CrossRef] [PubMed]
  36. Buades-Reinés, J.; Raya-Cruz, M.; Gallego-Lezaún, C.; Ripoll-Vera, T.; Usón-Martín, M.; Andreu-Serra, H.; Cisneros-Barroso, E. Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: A comparison between late- and early-onset disease. J. Peripher. Nerv. Syst. 2016, 21, 352–356. [Google Scholar] [CrossRef] [PubMed]
  37. Munar-Qués, M.; Saraiva, M.J.; Viader-Farré, C.; Zabay-Becerril, J.M.; Mulet-Ferrer, J. Genetic epidemiology of familial amyloid polyneuropathy in the Balearic Islands (Spain). Amyloid 2005, 12, 54–61. [Google Scholar] [CrossRef] [PubMed]
  38. Ortiz, M.A.H.; Estarellas, B.L.; Mateo, L.P.; Simonet, B.S. Aprovechamiento de recursos cupríferos en la edad del bronce de menorca: La mina de sa mitja lluna (Illa den Colom). Cuad. Prehist. Arqueol. Univ. Granada 2014, 24, 85–109. [Google Scholar]
  39. Hermanns, M.H. Avances en el estudio histórico de la mina de galena de Bunyola (isla de Mallorca). Sagvntvm 2014, 46, 189–200. [Google Scholar]
  40. Vicens, D.; Ginard, A.; Crespí, D.; Bover, P.; Gràcia, F. The endocarst and mines of the serra de na Burguesa (Mallorca, Balearic Islands). 1. Current knowledge speleogenetic, topographic, mining and speleothems forms. Bolleti Soc. d’Hist. Nat. Balear. 2011, 54, 117–132. [Google Scholar]
  41. Yoshioka, K.; Furuya, H.; Sasaki, H.; Saraiva, M.J.M.; Costa, P.P.; Sakaki, Y. Haplotype analysis of familial amyloidotic polyneuropathy. Evidence for multiple origins of the Val----Met mutation most common to the disease. Hum. Genet. 1989, 82, 9–13. [Google Scholar] [CrossRef]
  42. Holmgren, G.; Wikström, L.; Lundgren, H.; Suhr, O.B. Discordant penetrance of the trait for familial amyloidotic polyneuropathy in two pairs of monozygotic twins. J. Intern. Med. 2004, 256, 453–456. [Google Scholar] [CrossRef]
  43. Weihed, P.; Bergman, J.; Bergström, U. Métallogeny and tectonic evolution of the early proterozoic skellefte district, Northern Sweden. Precambrian Res. 1992, 58, 143–167. [Google Scholar] [CrossRef]
  44. Hellman, U.; Alarcon, F.; Lundgren, H.-E.; Suhr, O.B.; Bonaiti-Pellié, C.; Planté-Bordeneuve, V. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population. Amyloid 2008, 15, 181–186. [Google Scholar] [CrossRef] [PubMed]
  45. Olsson, M.; Jonasson, J.; Cederquist, K.; Suhr, O.B. Frequency of the transthyretin Val30Met mutation in the northern Swedish population. Amyloid 2014, 21, 18–20. [Google Scholar] [CrossRef] [PubMed]
  46. Nordberg, G.; Costa, M. Handbook on the Toxicology of Metals, 5th ed.; Academic Press: Cambridge, MA, USA, 2022. [Google Scholar]
  47. Saporta, M.A.d.C.; Plante-Bordeneuve, V.; Misrahi, M.; Cruz, M.W. Discordant expression of familial amyloid polyneuropathy in monozygotic Brazilian twins. Amyloid 2009, 16, 38–41. [Google Scholar] [CrossRef]
Figure 1. (A) Distribution of hATTR clusters across the world. (B) Distribution of hATTR cases in Japan, together with observed point mutations in the TTR protein. Image by PR, based on the information in Figures 1 and 2 in Araki and Ando, 2010 [8].
Figure 1. (A) Distribution of hATTR clusters across the world. (B) Distribution of hATTR cases in Japan, together with observed point mutations in the TTR protein. Image by PR, based on the information in Figures 1 and 2 in Araki and Ando, 2010 [8].
Biomolecules 14 00652 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Roos, P.M.; Wärmländer, S.K.T.S. Hereditary Transthyretin Amyloidosis (hATTR) with Polyneuropathy Clusters Are Located in Ancient Mining Districts: A Possible Geochemical Origin of the Disease. Biomolecules 2024, 14, 652. https://doi.org/10.3390/biom14060652

AMA Style

Roos PM, Wärmländer SKTS. Hereditary Transthyretin Amyloidosis (hATTR) with Polyneuropathy Clusters Are Located in Ancient Mining Districts: A Possible Geochemical Origin of the Disease. Biomolecules. 2024; 14(6):652. https://doi.org/10.3390/biom14060652

Chicago/Turabian Style

Roos, Per M., and Sebastian K. T. S. Wärmländer. 2024. "Hereditary Transthyretin Amyloidosis (hATTR) with Polyneuropathy Clusters Are Located in Ancient Mining Districts: A Possible Geochemical Origin of the Disease" Biomolecules 14, no. 6: 652. https://doi.org/10.3390/biom14060652

APA Style

Roos, P. M., & Wärmländer, S. K. T. S. (2024). Hereditary Transthyretin Amyloidosis (hATTR) with Polyneuropathy Clusters Are Located in Ancient Mining Districts: A Possible Geochemical Origin of the Disease. Biomolecules, 14(6), 652. https://doi.org/10.3390/biom14060652

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop